Post-treatment with nicotinamide (vitamin B3) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague–Dawley and Wistar rats-Reference-Cited by-同舟云学术

Post-treatment with nicotinamide (vitamin B3) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague–Dawley and Wistar rats

Published:2000-03 Issue:2-3 Volume:281 Page:111-114
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Sakakibara Yohtaro,Mitha Alim P.,Ogilvy Christopher S.,Maynard Kenneth I.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference20 articles.

1. Gender-linked brain injury in experimental stroke;Alkayed;Stroke,1998

2. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats;Ayoub;Neurosci. Lett.,1999

3. Delayed treatment with nicotinamide improves neurologic outcome and reduces infarction volume in transient focal cerebral ischemia in rats;Ayoub;Soc. Neurosci. Abstr.,1999

4. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate;Beal;Ann. Neurol.,1994

5. Thrombolysis in myocardial infarction investigators;Becker;Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann. Intern. Med.,1994

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery Through Neuronal Changes in the Hippocampus of Rats with Permanent Middle Cerebral Artery Occlusion;Neuroscience;2024-06

2. NAD⁺ precursor nutritional supplements sensitize the brain to future ischemic events;Journal of Cerebral Blood Flow & Metabolism;2023-02-22

3. Research Progress of H2S Donors Conjugate Drugs Based on ADTOH;Molecules;2022-12-31

4. Antioxidant therapies in traumatic brain injury;Neurochemistry International;2022-01

5. Molecular, Cellular, and Behavioural Effects Produced by Perinatal Asphyxia: Protection by Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibition;Handbook of Neurotoxicity;2022